MYC and Burkitt lymphoma: Combining specific lymphoma DNA parameters including but not limited to the c-MYC translocation with EBV-DNA characteristics such as sequencing-based quantification and fragment size profiling may further strengthen the possibility of early detection of EBV-driven BL through cfDNA.